Substituted quinoline-4-carboxylic hydrazides as NK-2/NK-3 receptor ligands

Details for Australian Patent Application No. 2004210774 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Macleod, Angus Murray; Chambers, Mark Stuart; Jones, Philip

Agent Spruson & Ferguson

Pub. Number AU-A-2004210774

PCT Pub. Number WO2004/072045

Priority 0303086.3 11.02.03 GB

Filing date 3 February 2004

Wipo publication date 26 August 2004

International Classifications

C07D 215/52 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 031/47 - Quinolines

Event Publications

28 July 2005 PCT application entered the National Phase

  PCT publication WO2004/072045 Priority application(s): WO2004/072045

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210775-An electrostatic atomiser

2004210753-Chemical derivatives binding very specifically with G-quadruplex DNA structures and use thereof as a specific anticancer agent